drugset / Trial / NCT07655804
Subcutaneous Calcitonin in Acute Herpes Zoster
RandomizedParallel-groupDouble-blindPrevention
Summary
This prospective randomized controlled study will be conducted to evaluate the effect of adding calcitonin to the standard treatment protocol in patients with acute herpes zoster infection.
Timeline
- Start
- 2026-07-01
- Primary completion
- 2027-04-01
- Completion
- 2027-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcitonin | Protein / enzyme biologic | 100 iu | Subcutaneous |